RecruitingPhase 1Phase 2

Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

NCT05329532

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Brighton and Sussex University Hospital

Brighton, Default, United Kingdom

+15 additional locations

Contact

Robert Miller

Save this trial

Brighton and Sussex University HospitalBrighton, Default, United Kingdom
Velindre Cancer CentreCardiff, Default, United Kingdom
Edinburgh Cancer Centre (NHS Lothian)Edinburgh, Default, United Kingdom
Royal Surrey NHS FoundationGuildford, Default, United Kingdom
Imperial College Healthcare NHS TrustLondon, Default, United Kingdom
Mount VernonLondon, Default, United Kingdom
University College London Hospital NHS Foundation TrustLondon, Default, United Kingdom
Christie NHS Foundation TrustManchester, Default, United Kingdom
Nottingham University Hospitals Cancer CentreNottingham, Default, United Kingdom
Lancashire Teaching Hospitals NHS Foundation TrustPreston, Default, United Kingdom
Sheffield Teaching Hospital NHS Foundation TrustSheffield, Default, United Kingdom
The Royal Marsden NHS Foundation TrustSutton, Default, United Kingdom
Belfast City HospitalBelfast, United Kingdom
Addenbrooke's Hospital, Cambridge University HospitalsCambridge, United Kingdom
The Clatterbridge Cancer Centre NHS Foundation TrustLiverpool, United Kingdom
Torbay and South Devon NHS Foundation TrustTorquay, United Kingdom